|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Less: Net income (loss) attributable to noncontrolling interests | |||||
| Net income attributable to MHFG shareholders | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Provision (credit) for credit losses | |||||
| Investment losses (gains)—net | |||||
| Equity in losses (earnings) of equity method investees—net | |||||
| Foreign exchange losses (gains)—net | |||||
| Deferred income tax expense (benefit) | |||||
| Net change in trading account assets | |||||
| Net change in trading account liabilities | |||||
| Net change in loans held for sale | |||||
| Net change in accrued income | |||||
| Net change in accrued expenses | |||||
| Other—net | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sales of Available-for-sale securities | |||||
| Proceeds from sales of Equity securities | |||||
| Proceeds from maturities of Available-for-sale securities | |||||
| Proceeds from maturities of Held-to-maturity securities | |||||
| Purchases of Available-for-sale securities | |||||
| Purchases of Held-to-maturity securities | |||||
| Purchases of Equity securities | |||||
| Proceeds from sales of loans | |||||
| Net change in loans | |||||
| Net change in call loans and funds sold, and receivables under resale agreements and securities borrowing transactions | |||||
| Proceeds from sales of premises and equipment | |||||
| Purchases of premises and equipment | |||||
| Proceeds from sales of investments in subsidiaries (affecting the scope of consolidation) | |||||
| Purchases of investments in subsidiaries (affecting the scope of consolidation) | |||||
| Payments for sales of investments in subsidiaries (affecting the scope of consolidation) | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in deposits | |||||
| Net change in call money and funds purchased, and payables under repurchase agreements and securities lending transactions | |||||
| Net change in due to trust accounts | |||||
| Net change in other short-term borrowings | |||||
| Proceeds from issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
| Proceeds from noncontrolling interests | |||||
| Payments to noncontrolling interests | |||||
| Proceeds from sales of treasury stock | |||||
| Purchases of treasury stock | |||||
| Dividends paid | |||||
| Dividends paid to noncontrolling interests | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of fiscal year | |||||
| Cash and cash equivalents at end of fiscal year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Noncash investing activities: | |||||
| Transfer of loans into loans held for sale | |||||
| Transfer of loans held-for-sale into loans | |||||
Loading...